Breast  ||| S:0 E:7 ||| JJ
health  ||| S:7 E:14 ||| NN
global  ||| S:14 E:21 ||| JJ
initiative  ||| S:21 E:32 ||| NN
( ||| S:32 E:33 ||| -LRB-
BHGI ||| S:33 E:37 ||| NNP
)  ||| S:37 E:39 ||| -RRB-
outline  ||| S:39 E:47 ||| NN
for  ||| S:47 E:51 ||| IN
program  ||| S:51 E:59 ||| NN
development  ||| S:59 E:71 ||| NN
in  ||| S:71 E:74 ||| IN
Latin  ||| S:74 E:80 ||| NNP
America  ||| S:80 E:88 ||| NNP
The  ||| S:88 E:92 ||| NNP
Breast  ||| S:92 E:99 ||| NNP
Health  ||| S:99 E:106 ||| NNP
Global  ||| S:106 E:113 ||| NNP
Initiative  ||| S:113 E:124 ||| NNP
( ||| S:124 E:125 ||| -LRB-
BHGI ||| S:125 E:129 ||| NNP
)  ||| S:129 E:131 ||| -RRB-
applied  ||| S:131 E:139 ||| VBD
an  ||| S:139 E:142 ||| DT
evidence-based  ||| S:142 E:157 ||| JJ
consensus  ||| S:157 E:167 ||| NN
review  ||| S:167 E:174 ||| NN
process  ||| S:174 E:182 ||| NN
to  ||| S:182 E:185 ||| TO
develop  ||| S:185 E:193 ||| VB
guidelines  ||| S:193 E:204 ||| NNS
for  ||| S:204 E:208 ||| IN
breast  ||| S:208 E:215 ||| JJ
cancer  ||| S:215 E:222 ||| NN
early  ||| S:222 E:228 ||| JJ
detection ||| S:228 E:237 ||| NN
,  ||| S:237 E:239 ||| ,
diagnosis ||| S:239 E:248 ||| NN
,  ||| S:248 E:250 ||| ,
and  ||| S:250 E:254 ||| CC
treatment  ||| S:254 E:264 ||| NN
in  ||| S:264 E:267 ||| IN
low-  ||| S:267 E:272 ||| JJ
and  ||| S:272 E:276 ||| CC
middle-income  ||| S:276 E:290 ||| JJ
countries  ||| S:290 E:300 ||| NNS
( ||| S:300 E:301 ||| -LRB-
LMCs ||| S:301 E:305 ||| NNP
)  ||| S:305 E:307 ||| -RRB-
including  ||| S:307 E:317 ||| VBG
those  ||| S:317 E:323 ||| DT
in  ||| S:323 E:326 ||| IN
Latin  ||| S:326 E:332 ||| NNP
America ||| S:332 E:339 ||| NNP
.  ||| S:339 E:341 ||| .
Breast  ||| S:341 E:348 ||| JJ
cancer  ||| S:348 E:355 ||| NN
outcomes  ||| S:355 E:364 ||| NN
correlate  ||| S:364 E:374 ||| NN
with  ||| S:374 E:379 ||| IN
the  ||| S:379 E:383 ||| DT
degree  ||| S:383 E:390 ||| NN
to  ||| S:390 E:393 ||| TO
which  ||| S:393 E:399 ||| WDT
1 ||| S:399 E:400 ||| CD
)  ||| S:400 E:402 ||| -RRB-
cancers  ||| S:402 E:410 ||| NNS
are  ||| S:410 E:414 ||| VBP
detected  ||| S:414 E:423 ||| VBN
early ||| S:423 E:428 ||| RB
,  ||| S:428 E:430 ||| ,
2 ||| S:430 E:431 ||| LS
)  ||| S:431 E:433 ||| -RRB-
cancers  ||| S:433 E:441 ||| NNS
can  ||| S:441 E:445 ||| MD
be  ||| S:445 E:448 ||| VB
diagnosed  ||| S:448 E:458 ||| VBN
correctly ||| S:458 E:467 ||| RB
,  ||| S:467 E:469 ||| ,
and  ||| S:469 E:473 ||| CC
3 ||| S:473 E:474 ||| LS
)  ||| S:474 E:476 ||| -RRB-
proper  ||| S:476 E:483 ||| JJ
multimodality  ||| S:483 E:497 ||| JJ
treatment  ||| S:497 E:507 ||| NN
can  ||| S:507 E:511 ||| MD
be  ||| S:511 E:514 ||| VB
provided  ||| S:514 E:523 ||| VBN
in  ||| S:523 E:526 ||| IN
a  ||| S:526 E:528 ||| DT
timely  ||| S:528 E:535 ||| JJ
fashion ||| S:535 E:542 ||| NN
.  ||| S:542 E:544 ||| .
Cancer  ||| S:544 E:551 ||| NN
prevention  ||| S:551 E:562 ||| NN
through  ||| S:562 E:570 ||| IN
health  ||| S:570 E:577 ||| NN
behavior  ||| S:577 E:586 ||| NN
modification  ||| S:586 E:599 ||| NN
may  ||| S:599 E:603 ||| MD
influence  ||| S:603 E:613 ||| VB
breast  ||| S:613 E:620 ||| JJ
cancer  ||| S:620 E:627 ||| NN
incidence  ||| S:627 E:637 ||| NN
in  ||| S:637 E:640 ||| IN
LMCs ||| S:640 E:644 ||| JJ
.  ||| S:644 E:646 ||| .
Diagnosing  ||| S:646 E:657 ||| JJ
breast  ||| S:657 E:664 ||| NN
cancer  ||| S:664 E:671 ||| NN
at  ||| S:671 E:674 ||| IN
earlier  ||| S:674 E:682 ||| JJR
stages  ||| S:682 E:689 ||| NNS
will  ||| S:689 E:694 ||| MD
reduce  ||| S:694 E:701 ||| VB
breast  ||| S:701 E:708 ||| JJ
cancer  ||| S:708 E:715 ||| NN
mortality ||| S:715 E:724 ||| NN
.  ||| S:724 E:726 ||| .
Programs  ||| S:726 E:735 ||| NNS
to  ||| S:735 E:738 ||| TO
promote  ||| S:738 E:746 ||| VB
breast  ||| S:746 E:753 ||| JJ
self-awareness  ||| S:753 E:768 ||| NN
and  ||| S:768 E:772 ||| CC
clinical  ||| S:772 E:781 ||| JJ
breast  ||| S:781 E:788 ||| NN
examination  ||| S:788 E:800 ||| NN
and  ||| S:800 E:804 ||| CC
resource-adapted  ||| S:804 E:821 ||| JJ
mammographic  ||| S:821 E:834 ||| JJ
screening  ||| S:834 E:844 ||| NNS
are  ||| S:844 E:848 ||| VBP
important  ||| S:848 E:858 ||| JJ
early  ||| S:858 E:864 ||| JJ
detection  ||| S:864 E:874 ||| JJ
steps ||| S:874 E:879 ||| NNS
.  ||| S:879 E:881 ||| .
Screening  ||| S:881 E:891 ||| JJ
mammography  ||| S:891 E:903 ||| NN
has  ||| S:903 E:907 ||| VBZ
been  ||| S:907 E:912 ||| VBN
shown  ||| S:912 E:918 ||| VBN
to  ||| S:918 E:921 ||| TO
reduce  ||| S:921 E:928 ||| VB
breast  ||| S:928 E:935 ||| JJ
cancer  ||| S:935 E:942 ||| NN
mortality ||| S:942 E:951 ||| NN
,  ||| S:951 E:953 ||| ,
but  ||| S:953 E:957 ||| CC
is  ||| S:957 E:960 ||| VBZ
cost  ||| S:960 E:965 ||| NN
prohibitive  ||| S:965 E:977 ||| NN
in  ||| S:977 E:980 ||| IN
some  ||| S:980 E:985 ||| DT
settings ||| S:985 E:993 ||| NNS
.  ||| S:993 E:995 ||| .
Breast  ||| S:995 E:1002 ||| JJ
imaging ||| S:1002 E:1009 ||| NN
,  ||| S:1009 E:1011 ||| ,
initially  ||| S:1011 E:1021 ||| RB
with  ||| S:1021 E:1026 ||| IN
ultrasound  ||| S:1026 E:1037 ||| NN
and ||| S:1037 E:1040 ||| CC
,  ||| S:1040 E:1042 ||| ,
at  ||| S:1042 E:1045 ||| IN
higher  ||| S:1045 E:1052 ||| JJR
resource  ||| S:1052 E:1061 ||| NN
levels  ||| S:1061 E:1068 ||| NNS
with  ||| S:1068 E:1073 ||| IN
diagnostic  ||| S:1073 E:1084 ||| JJ
mammography ||| S:1084 E:1095 ||| NN
,  ||| S:1095 E:1097 ||| ,
improves  ||| S:1097 E:1106 ||| VBZ
preoperative  ||| S:1106 E:1119 ||| JJ
diagnostic  ||| S:1119 E:1130 ||| JJ
assessment  ||| S:1130 E:1141 ||| NN
and  ||| S:1141 E:1145 ||| CC
permits  ||| S:1145 E:1153 ||| VBZ
image-guided  ||| S:1153 E:1166 ||| JJ
needle  ||| S:1166 E:1173 ||| NN
sampling ||| S:1173 E:1181 ||| NN
.  ||| S:1181 E:1183 ||| .
Multimodality  ||| S:1183 E:1197 ||| JJ
therapy  ||| S:1197 E:1205 ||| NN
includes  ||| S:1205 E:1214 ||| VBZ
surgery ||| S:1214 E:1221 ||| NN
,  ||| S:1221 E:1223 ||| ,
radiation ||| S:1223 E:1232 ||| NN
,  ||| S:1232 E:1234 ||| ,
and  ||| S:1234 E:1238 ||| CC
systemic  ||| S:1238 E:1247 ||| JJ
therapies ||| S:1247 E:1256 ||| NNS
.  ||| S:1256 E:1258 ||| .
